Browsing by Author Martínez Pinteño, Albert
Showing results 1 to 13 of 13
| Issue Date | Title | Author(s) |
|---|---|---|
| 19-Oct-2021 | A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood. | Gassó Astorga, Patricia; Rodríguez Ferret, Natalia; Martínez Pinteño, Albert; Mezquida Mateos, Gisela; Ribeiro, M.; González Peñas, Javier; Zorrilla, Iñaki; Martínez Sadurní, L.; Rodriguez Jimenez, Roberto; Corripio, Iluminada; Sarró, Salvador; Ibáñez, A.; Usall i Rodié, Judith; Lobo, A.; Morén Núñez, Constanza; Cuesta, Manuel J.; Parellada, Mara; González-Pinto, Ana; Berrocoso, Esther; Bernardo Arroyo, Miquel; Mas Herrero, Sergi; 2EPs Group |
| Jan-2018 | Different modulation of RPS6 phosphorylation by risperidone in striatal cells sub populations: involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms in mice | García Cerro, Susana; Mas Herrero, Sergi; Gortat, Anna; Sindreu Balet, Carlos; Martínez Pinteño, Albert; Marmol Carrera, Federico; Boloc, Daniel; Rodríguez Ferret, Natalia; Gassó Astorga, Patricia; Lafuente, Amàlia, 1952-2022 |
| 14-Dec-2022 | Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia. | Martínez Pinteño, Albert; Rodríguez Ferret, Natalia; Olivares Berjaga, David; Madero García, Santiago; Gómez, M; Prohens Coll, Llucia; García Rizo, Clemente; Mas Herrero, Sergi; Morén Núñez, Constanza; Parellada Rodón, Eduard; Gassó Astorga, Patricia |
| 1-Feb-2024 | Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia | Olivares Berjaga, David; Martínez Pinteño, Albert; Rodríguez Ferret, Natalia; Madero García, Santiago; Prohens Coll, Llucia; Mas Herrero, Sergi; Morén Núñez, Constanza; Parellada Rodón, Eduard; Gassó Astorga, Patricia; Martínez-Serrano, Irene |
| 5-Jan-2024 | Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk | Prohens Coll, Llucia; Rodríguez Ferret, Natalia; Gonzàlez Segura, Àlex; Martínez Pinteño, Albert; Olivares Berjaga, David; Martínez-Serrano, Irene; González, Aitor; Mezquida Mateos, Gisela; Parellada, Mara; Cuesta, Manuel J.; Bernardo Arroyo, Miquel; Gassó Astorga, Patricia; Mas Herrero, Sergi |
| 13-Aug-2021 | Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data | Martínez Pinteño, Albert; Gassó Astorga, Patricia; Prohens Coll, Llucia; Gonzàlez Segura, Àlex; Parellada, Mara; Saiz Ruiz, Jerónimo; Cuesta, Manuel J.; Bernardo Arroyo, Miquel; Lafuente, Amàlia, 1952-2022; Mas Herrero, Sergi; Rodríguez Ferret, Natalia |
| 2023 | Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode | Gonzalez Segura, Àlex; Mezquida Mateos, Gisela; Martínez Pinteño, Albert; Gassó Astorga, Patricia; Rodríguez, Natàlia; Moreno Izco, Lucía; Amoretti Guadall, Silvia; Bioque Alcázar, Miquel; Lobo, Antonio; González-Pinto, Ana; García-Alcon, Alicia; Roldán-Bejarano, Alexandra; Vieta i Pascual, Eduard, 1963-; Serna Gómez, Elena de la; Toll Privat, Alba; Cuesta, Manuel J.; Mas, Sergi; Bernardo Arroyo, Miquel; PEPs Group |
| 31-May-2022 | Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort | Segura, Alex G.; Martínez Pinteño, Albert; Gassó Astorga, Patricia; Rodríguez Ferret, Natalia; Bioque Alcázar, Miquel; Cuesta, Manuel J.; González Peñas, Javier; García Rizo, Clemente; Lobo, Antonio; González-Pinto, Ana; García Alcón, Alicia; Roldán, Alexandra; Vieta i Pascual, Eduard, 1963-; Castro Fornieles, Josefina; Mané Santacana, Anna; Saiz Ruiz, Jerónimo; Bernardo Arroyo, Miquel; Mas Herrero, Sergi; Mezquida Mateos, Gisela; PEPs Group |
| 13-Jul-2022 | Modelos experimentales aplicados al estudio de la eficacia y la seguridad de los antipsicóticos | Martínez Pinteño, Albert |
| 20-Jan-2023 | Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell Cultures | Gassó Astorga, Patricia; Martínez Pinteño, Albert; Rodríguez Ferret, Natalia; Madero García, Santiago; Sureda-Gómez, Marta; Segura, Alex G.; García Rizo, Clemente; Morén Núñez, Constanza; Mas Herrero, Sergi; Parellada Rodón, Eduard |
| 15-May-2020 | Response to fluoxetine in children and adolescents: a weighted gene co-expression network analysis of peripheral blood | Torres, Teresa; Boloc, Daniel; Rodríguez Ferret, Natalia; Blázquez, Ana; Plana, Maria Teresa; Varela, Eva; Gassó Astorga, Patricia; Martínez Pinteño, Albert; Lázaro García, Luisa; Arnaiz Gargallo, Juan Alberto; Mas Herrero, Sergi |
| 17-Nov-2022 | Systematic review of the therapeutic role of apoptotic inhibitors in neurodegeneration and their potential use in schizophrenia | Martínez Pinteño, Albert; Morén Núñez, Constanza; Treder, Nina; Rodríguez Ferret, Natalia; Arbelo, Néstor; Madero García, Santiago; Gómez Ramiro, Marta; Mas Herrero, Sergi; Gassó Astorga, Patricia; Parellada Rodón, Eduard |
| 5-Jan-2023 | The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia | Treder, Nina; Martínez Pinteño, Albert; Rodríguez Ferret, Natalia; Arbelo, Néstor; Madero García, Santiago; Gómez, M; García Rizo, Clemente; Mas Herrero, Sergi; Gassó Astorga, Patricia; Parellada Rodón, Eduard; Morén Núñez, Constanza |